Trial Profile
A Multi-center, Double Blind, Randomized, Parallel Group Study to Evaluate the Effects of Valsartan on Proteinuria in Hypertensive Subjects With Type 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2011
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Diabetic nephropathies; Hypertension; Proteinuria; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DROP
- Sponsors Novartis
- 07 Nov 2011 Actual initiation date (Nov 2002) added and official title amended as reported by ClinicalTrials.gov.
- 11 Aug 2011 Results published in the Journal of Hypertension.
- 05 Nov 2010 New trial record.